Expression of the protein kinase p-68 recognized by the monoclonal antibody TJ4C4 in human lung neoplasms

Keyphrases

• Monoclonal Antibody 100%
• Protein Kinase 100%
• Lung Neoplasms 100%
• Human Lung 100%
• Tumor 66%
• Cellular Proteins 66%
• Squamous Cell Carcinoma (SqCC) 66%
• Protein Synthesis 66%
• Pancreatic Adenocarcinoma 66%
• Pleural Neoplasms 66%
• Large Cell Carcinoma 33%
• Adenocarcinoma Cells 33%
• Interferon-α (IFN-α) 33%
• Clinically Significant 33%
• Carcinoid Tumor 33%
• Tumor Subtype 33%
• Differential Expression 33%
• Cellular Differentiation 33%
• Biological Markers 33%
• Viral Proteins 33%
• Neuroendocrine Tumor 33%
• Eukaryotic Cells 33%
• Biosynthetic Potential 33%
• Formalin-fixed 33%
• Small Cell Carcinoma 33%
• Mesothelioma 33%
• Bronchioloalveolar Carcinoma 33%
• Poor Differentiation 33%
• Well-differentiated 33%
• Relative Intensity 33%
• Atypical Carcinoid 33%
• Immunoperoxidase 33%
• Papillary Adenocarcinoma 33%
• Microscopic Evaluation 33%
• Pulmonary Neoplasm 33%
• Degree of Differentiation 33%
• Glandular Differentiation 33%

Medicine and Dentistry

• Monoclonal Antibody 100%
• Lung Tumor 100%
• Protein Kinases 100%
• Adenocarcinoma 75%
• Carcinoid 50%
• Squamous Cell Carcinoma 50%
• Pleura Tumor 50%
• Tumor 50%
• Protein Synthesis 50%
• Large Cell Carcinoma 25%
• Neoplasm 25%
• Cell Differentiation 25%
• Carcinoma 25%
• Biological Marker 25%
• Neuroendocrine Tumor 25%
• Small-Cell Carcinoma 25%
• Peroxidase 25%
• Mesothelioma 25%
• Interferon Alfa 25%
• Eukaryotic Cell 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Monoclonal Antibody 100%
• Lung Tumor 100%
• Protein Kinases 100%
• Adenocarcinoma 75%
• Cell Protein 50%
• Squamous Cell Carcinoma 50%
• Carcinoid 50%
• Pleura Tumor 50%
• Neoplasm 25%
• Biological Marker 25%
• Carcinoma 25%
• Viral Protein 25%
• Alpha Interferon 25%
• Large Cell Carcinoma 25%
• Small Cell Carcinoma 25%
• Peroxidase 25%
• Neuroendocrine Tumor 25%
• Mesothelioma 25%